13 patents
Utility
Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity
19 Dec 23
Peter Mikochik, Joseph Vacca, David Freeman, Andrew S. Tasker
Filed: 15 Sep 21
Utility
CRYSTALLINE SUCCINATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[1,2-a]PYRAZIN-8-AMINE
25 May 23
Peter A. Blomgren, Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell, Aaron C. Schmitt, Jin-Ming Xiong, Jianjun Xu, Sundaramoorthi Swaminathan, Zhongdong Zhao
Filed: 18 Nov 22
Utility
CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORS
30 Mar 23
Patricia Andres, Peter C. Fung, Pierre Giguere, Chiajen Lai, Craig Stewart, Jing Teng, Duong D. Tran, Iva Trantcheva, Yarmuch
Filed: 19 May 22
Utility
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine
6 Dec 22
Peter A. Blomgren, Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell, Aaron C. Schmitt, Sundaramoorthi Swaminathan, Jin-Ming Xiong, Jianjun Xu, Zhongdong Zhao
Filed: 28 Oct 20
Utility
Hydrates of Polymorphs of 6-(1H-INDAZOL-6-YL)-N-(4-MORPHOLINOPHENYL)-2,3-DIHYDROIMIDAZO[1,2-A]PYRAZIN-8-AMINE Bis-mesylate As Syk Inhibitors
25 Aug 22
Tim G. Elford, Peter Chee-Chu Fung, Paul Robert Hartmeier, Jesper Alexis Jernelius, Henry Morrison
Filed: 4 May 22
Utility
Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors
12 Jul 22
Tim G. Elford, Peter Chee-Chu Fung, Paul Robert Hartmeier, Jesper Alexis Jernelius, Henry Morrison
Filed: 10 Aug 18
Utility
Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors
24 May 22
Patricia Andres, Peter C. Fung, Pierre Giguere, Chiajen Lai, Craig Stewart, Jing Teng, Duong D. Tran, Iva Trantcheva, Brian Yarmuch
Filed: 20 Feb 20
Utility
Compounds, Compositions, and Methods for Modulating CDK9 Activity
6 Jan 22
Peter MIKOCHIK, Joseph VACCA, David FREEMAN, Andrew S. TASKER
Filed: 15 Sep 21
Utility
Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity
26 Oct 21
Peter Mikochik, Joseph Vacca, David Freeman, Andrew S. Tasker
Filed: 29 Oct 19
Utility
CRYSTALLINE MONOMESYLATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[1,2-a]PYRAZIN-8-AMINE
4 Mar 21
Peter A. Blomgren, Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell, Aaron C. Schmitt, Sundaramoorthi Swaminathan, Jin-Ming Xiong, Jianjun Xu, Zhongdong Zhao
Filed: 28 Oct 20
Utility
Imidazopyridines Syk inhibitors
23 Nov 20
Certain imidazopyridines and pharmaceutical compositions thereof are provided herein.
Peter A. Blomgren, Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Aaron C. Schmitt, Jianjun Xu, Zhongdong Zhao
Filed: 5 Sep 18
Utility
Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine
9 Nov 20
Peter A. Blomgren, Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell, Aaron C. Schmitt, Sundaramoorthi Swaminathan, Jin-Ming Xiong, Jianjun Xu, Zhongdong Zhao
Filed: 14 May 19
Utility
Compounds, Compositions, and Methods for Modulating CDK9 Activity
29 Apr 20
Peter MIKOCHIK, Joseph VACCA, David FREEMAN, Andrew S. TASKER
Filed: 28 Oct 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first